Watch the archived webinar on The Role of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) presented by Renato Martins, MD, MPH, Medical Director, Outpatient General Oncology/Hematology, Seattle Cancer Care Alliance; Medical Director, Thoracic/Head and Neck Oncology; Professor, University of Washington School of Medicine.
• Current non-small cell lung cancer (NSCLC) treatment planning with treatment algorithm
• Present and evolving uses of PD-1 inhibitors in NSCLC—clinical evidence (including PD-L1+ biomarker status/results)
• Additional immunotherapies in development for NSCLC: PD-L1 inhibitors (status and clinical results)
• Case study and expert interpretation
Please send your comments and feedback to email@example.com.